Sun Pharmaceutical Industries has announced a significant expansion move as its subsidiary approved an investment of ₹3,000 crore to establish a new greenfield formulations manufacturing facility in Madhya Pradesh. This step highlights the company’s strategy to boost domestic production capacity and strengthen its supply chain to meet India’s rising demand for high-quality medicines. The investment is expected to create large-scale job opportunities and position Sun Pharma for stronger long-term growth, while also enhancing its global competitiveness in the pharmaceutical market. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only .Investors must verify information before investing and consider their financial position and risk profile. please read full disclosure disclaimer in given link

#StockInNews#WatchOutFor

650 likes·82 comments